Efficacy of combination therapy with mexiletine and a type IA agent for inducible ventricular tachyarrhythmias secondary to coronary artery disease

This publication has 14 references indexed in Scilit:

• Mexiletine in the treatment of resistant ventricular arrhythmias: enhancement of efficacy and reduction of dose-related side effects by combination with quinidine.
  Circulation, 1983
• Predictors of the Success or failure of medical therapy in patients with chronic recurrent sustained ventricular tachycardia: A discriminant analysis
  Journal of the American College of Cardiology, 1983
• Lack of effectiveness of oral mexiletine in patients with drug-refractory paroxysmal sustained ventricular tachycardia: A study utilizing programmed stimulation
  The American Journal of Cardiology, 1982
• Role of programmed stimulation in assessing vulnerability to ventricular arrhythmias
  American Heart Journal, 1982
• Mexiletine for refractory-ventricular arrhythmias: Results using serial electrophysiologic testing
  The American Journal of Cardiology, 1981
• Large dose procainamide therapy for ventricular tachyarrhythmia
  The American Journal of Cardiology, 1980
• Test of a model of antiarrhythmic drug action. Effects of quinidine and lidocaine on myocardial conduction.
  Circulation, 1980
• Recurrent sustained ventricular tachycardia 3. Role of the electrophysiologic study in selection of antiarrhythmic regimens.
  Circulation, 1978
• Antiarrhythmic drug effect assessed from ventricular arrhythmia reduction in the ambulatory electrocardiogram and treadmill test: Comparison of propranolol, procainamide and quinidine
  The American Journal of Cardiology, 1978
• Management of patients with malignant ventricular arrhythmias
  The American Journal of Cardiology, 1977